ADDF ADispell 170 awards.

We have identified a novel medication target that improves mental performance and compounds that action on that focus on to improve brain function. These money allows us to gain an improved understanding of the way the compounds affect diseases that cause cognition loss. ADispell’s unique approach to targeting memory loss holds great promise as cure for Alzheimer’s disease, said Howard Fillit, M.D., Executive Director for the ADDF. There are estimated to be more than 5 million individuals in the United States and more than 35 million individuals worldwide suffering from Alzheimer’s disease. SOURCE Alzheimer’s Medication Discovery Foundation..‘Although we are making main improvements in the usage of drugs, prevention should be addressed in a very forceful way clearly,’ he added. According to recent Globe Health Organization statistics, just 28 % of the world’s HIV/AIDS individuals are receiving anti-retroviral medications. Dr. Brian Gazzard, chairman of the British HIV Association, stated that while great advancements have been made in extending usage of anti-retrovirals, the disease continues to be running rampant in parts of Asia and Africa. ‘The HIV epidemic is actually uncontrolled, uncontrolled in Africa, uncontrolled completely in Asia at this time,’ he told reporters at the conference, which includes drawn 5,000 delegates from 133 countries.